BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33408831)

  • 21. Adolescent extra-truncal progressive macular hypomelanosis.
    Paquette GM; Sherman S; Akabane A; Harris JE
    Pediatr Dermatol; 2023; 40(4):702-705. PubMed ID: 36744793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of lymecycline and benzoyl peroxide for the treatment of progressive macular hypomelanosis: a prospective study.
    Cavalcanti SM; Querino MC; Magalhães V; França ER; Magalhães M; Alencar E
    An Bras Dermatol; 2011; 86(4):813-4. PubMed ID: 21987158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Idiopathic Guttate Hypomelanosis Treated with 308-nm Excimer Light and Topical Bimatoprost.
    Kreeshan FC; Madan V
    J Cutan Aesthet Surg; 2021; 14(1):115-117. PubMed ID: 34084020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anti-fungal resistant hypopigmented macules in an adolescent].
    Martínez Martínez ML; Azaña Defez JM; López Villaescusa MT; Gómez Sánchez M
    Semergen; 2012 Sep; 38(6):405-7. PubMed ID: 22935838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of progressive macular hypomelanosis successfully treated with benzoyl peroxide plus narrow-band UVB.
    Wu XG; Xu AE; Luo XY; Song XZ
    J Dermatolog Treat; 2010 Nov; 21(6):367-8. PubMed ID: 20524876
    [No Abstract]   [Full Text] [Related]  

  • 26.
    Petersen RL; Scholz CF; Jensen A; Brüggemann H; Lomholt HB
    Eur J Microbiol Immunol (Bp); 2017 Mar; 7(1):37-45. PubMed ID: 28386469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progressive macular hypomelanosis in a 16-year old.
    Perman M; Sheth P; Lucky AW
    Pediatr Dermatol; 2008; 25(1):63-5. PubMed ID: 18304157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical, pathologic, and ultrastructural studies of progressive macular hypomelanosis.
    Wu XG; Xu AE; Song XZ; Zheng JH; Wang P; Shen H
    Int J Dermatol; 2010 Oct; 49(10):1127-32. PubMed ID: 20931684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progressive macular hypomelanosis in Singapore: a clinico-pathological study.
    Kumarasinghe SP; Tan SH; Thng S; Thamboo TP; Liang S; Lee YS
    Int J Dermatol; 2006 Jun; 45(6):737-42. PubMed ID: 16796639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypopigmented macules of photodamaged skin and their treatment with topical tretinoin.
    Pagnoni A; Kligman AM; Sadiq I; Stoudemayer T
    Acta Derm Venereol; 1999 Jul; 79(4):305-10. PubMed ID: 10429990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrastructural findings in progressive macular hypomelanosis indicate decreased melanin production.
    Relyveld GN; Dingemans KP; Menke HE; Bos JD; Westerhof W
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):568-74. PubMed ID: 18266692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study.
    Asawanonda P; Klahan SO
    Photomed Laser Surg; 2010 Oct; 28(5):679-84. PubMed ID: 20961233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypomelanosis of Ito and Moyamoya disease.
    Rafay MF; Al-Futaisi A; Weiss S; Armstrong D
    J Child Neurol; 2005 Nov; 20(11):924-6. PubMed ID: 16417866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acquired disorders with hypopigmentation: A clinical approach to diagnosis and treatment.
    Saleem MD; Oussedik E; Picardo M; Schoch JJ
    J Am Acad Dermatol; 2019 May; 80(5):1233-1250.e10. PubMed ID: 30236514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strains of the Propionibacterium acnes type III lineage are associated with the skin condition progressive macular hypomelanosis.
    Barnard E; Liu J; Yankova E; Cavalcanti SM; Magalhães M; Li H; Patrick S; McDowell A
    Sci Rep; 2016 Aug; 6():31968. PubMed ID: 27555369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pigmentary mosaicism of the hypopigmented type (hypomelanosis of Ito): hypopigmented lesions with serrated and irregular borders.
    Oiso N; Kawada A
    Eur J Dermatol; 2014; 24(6):690-1. PubMed ID: 25179245
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo--a multicentre controlled study.
    Casacci M; Thomas P; Pacifico A; Bonnevalle A; Paro Vidolin A; Leone G
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):956-63. PubMed ID: 17659006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy, predictors of response, and long-term follow-up in patients with vitiligo treated with narrowband UVB phototherapy.
    Nicolaidou E; Antoniou C; Stratigos AJ; Stefanaki C; Katsambas AD
    J Am Acad Dermatol; 2007 Feb; 56(2):274-8. PubMed ID: 17224369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Celiac disease, phylloid hypomelanosis and autoimmune thyroiditis: a case report.
    Tosun MS; Ertekin V
    Turk J Pediatr; 2015; 57(6):639-641. PubMed ID: 27735809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypopigmented mycosis fungoides: a retrospective clinicohistopathologic study.
    Rodney IJ; Kindred C; Angra K; Qutub ON; Villanueva AR; Halder RM
    J Eur Acad Dermatol Venereol; 2017 May; 31(5):808-814. PubMed ID: 27515575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.